Endocrine disrupting compounds (EDCs) are defined as “chemicals that either mimic endogenous hormones, interfere with pharmacokinetics, or act by other mechanisms” (1). Adverse effects such as compromised reproductive fitness, functional or morphological birth defects, cancer, and altered immune functions, among others have been reported in the scientific literature (1, 2, 3). The term “endocrine disruptors” is used to describe substances that are not produced in the body but act by mimicking or antagonizing natural hormones. It is thought that EDCs may be responsible for some reproductive problems in both women and men as well as for the increases in the frequency of certain types of cancer. EDCs have also been linked to developmental deficiencies and learning disabilities in children. Because hormone receptor systems are similar in humans and animals, effects observed in wildlife species raise concerns of potential human health effects. During fetal development and early childhood, low-dose exposure to EDCs may have profound effects not observed in adults, such as reduced mental capacity and genital malformations. Evaluating potential low-dose effects of environmental estrogenic compounds has been identified as a major research priority.
KeywordsEndocrine Disruptor Powdered Activate Carbon Maximum Contaminant Level Endosulfan Sulfate Diethyl Phthalate
Unable to display preview. Download preview PDF.
- 1.US FDA, Endocrine Disruptor Knowledge Base (EDKB), US Food and Drug Administration, Web Site http://edkb.fda.gov/ (2006).
- 2.European Commission, Endocrine Disruptor, Web Site, http://europa.eu.int/comm/environment/endocrine (2006).
- 3.IPCS, Summary and Details: Scientific Facts on Endocrine Disruptors, International Program on Chemical Safety, Green Facts, http://www.greenfacts.org/endocrine-disruptors/ (2006).
- 4.R. K. Naz (ed.), Endocrine Disruptors: Effects on Male and Female Reproductive System, CRC Press, Boca Raton, FL, 1999.Google Scholar
- 5.G Chhanda, Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals, Proc. of the Society for Experimental Biology and Medicine. Vol. 224, pp. 61–68 (2000).Google Scholar
- 6.R. Triendl, Genes may solve hormone-disrupter debate, Robert. Nature 209, January 28, 2001.Google Scholar
- 7.US EPA, Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) Final Report, Office of Prevention, Pesticides and Toxic Substances, US Environmental Protection Agency, January (1999). http://www.epa.gov/scipoly/oscpendo/history/finalrpt.htm (2005).
- 8.K. Jesperson, Endocrine disruptors: what are they doing to you, National Drinking Water Clearing House. On Tap 2, 4, pp. 16–22 and 49, Winter (2003).Google Scholar
- 9.US EPA, Removal of Endocrine Disruptor Chemicals Using Drinking Water Treatment Processes, Technology Transfer Report No. EPA/625/R-00/015, The National Risk Management Research Laboratory, Office of Research and Development, US Environmental Protection Agency, Cincinnati, OH, March, 2001.Google Scholar
- 10.W. Rogan, and B. Gladen, et al., Neonatal effects of transplacental exposure to PCBs and DDE. J. Pediatr. 109, 335–341 (1996).Google Scholar
- 14.L. J. Guillette and D. A. Crain, Endocrine-disrupting contaminants and reproductive abnormalities in reptiles. Comments on Toxicol. 5, 381–399 (1996).Google Scholar
- 15.ATSDR, Agency for Toxic Substances and Disease Registry ToxFAQs. Endosulfan (1995). http://www.atsdr.cdc.gov/tfacts41.html (2006).
- 21.B. C. Gladen and W. J. Rogan, Effects of perinatal polychlorinated biphenyls and dichlorodiphenyl dichloroethene on later development, J. Pediatr. 113, 991–995 (1991).Google Scholar
- 24.C. Tohyama, Mechanisms of dioxin toxicity: implications for assessing risk to humans, Conference on Environmental Endocrine Disruptors, Colby-Sawyer College, New London, NH, June 6–11, 2004.Google Scholar
- 25.US Department of Health and Human Services, 2,3,7,8-Tetrachlorodibenzo p-Dioxin (TCDD); DIOXIN, CAS No. 1746-01-6, Public Health Service National Toxicology Program, 9th Report on Carcinogens, January, 2001.Google Scholar
- 26.US Department of Health and Human Services, Furan, CAS No. 110-00-9. 9th Report on Carcinogens, Public Health Service National Toxicology Program, January, 2001.Google Scholar
- 28.R. J. Maguire, Review of the persistence of nonylphenol and nonylphenol ethoxylates in aquatic environments. Water Qual. Res. J. Can. 34(1), 37–78 (1999).Google Scholar
- 29.R. Hauser, Phthalates: understanding human exposure and health risks, Conference on Environmental Endocrine Disruptors, Colby-Sawyer College, New London, NH, June 6–11, 2004.Google Scholar
- 30.I. ColÓn, D. Caro, C. J. Bourdony, and O. Rosario, Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ. Health Perspect. 108, September 9 (2000).Google Scholar
- 31.AWWA, ASCE, Water Treatment Plant Design, 3rd edn., McGraw-Hill Company, Inc., New York, NY, 1998.Google Scholar
- 32.US EPA, Technologies for Upgrading Existing or Designing New Drinking Water Treatment Facilities, EPA/625/4-89/023, US Environmental Protection Agency, March, 1990.Google Scholar
- 33.US EPA, Water on Tap: A Consumer′s Guide to the Nation′s Drinking Water, EPA/815/K-97/002. US Environmental Protection Agency, July, 1997.Google Scholar
- 34.US EPA, Small System Compliance Technology List for the Non-Microbial Contaminants Regulated Before 1996, EPA/815/R-98/002, US Environmental Protection Agency, September, 1998.Google Scholar
- 35.US EPA, Drinking Water Treatment, EPA/810/F-99/013, US Environmental Protection Agency, December, 1999.Google Scholar
- 36.L. K. Wang, Y. T. Hung, and N. K. Shammas (eds.), Physicochemical Treatment Processes, The Humana Press, Inc., Totowa, NJ, 2005.Google Scholar
- 37.L. K. Wang, Y. T. Hung, and N. K. Shammas (eds.), Advanced Physicochemical Treatment Processes, The Humana Press, Inc., Totowa, NJ, 2006.Google Scholar
- 38.Y. T. Hung, H. H. Lo, L. K. Wang, J. R. Taricska, and K. H. Li, Granular activated carbon adsorption, in Physicochemical Treatment Processes, L. K. Wang, Y. T. Hung, and N. K. Shammas (eds.), The Humana Press, Inc., Totowa, NJ, 2005.Google Scholar
- 39.N. K. Shammas, Coagulation and flocculation, in Physicochemical Treatment Processes, L. K. Wang, Y. T. Hung, and N. K. Shammas (eds.), The Humana Press, Inc., Totowa, NJ, 2005.Google Scholar
- 40.Y. T. Hung, J. R. Taricska, H. H. Lo, L. K. Wang, and K. H. Li, Powdered activated carbon adsorption, in Advanced Physicochemical Treatment Processes, L. K. Wang, Y. T. Hung, and N. K. Shammas (eds.), The Humana Press, Inc., Totowa, NJ, 2006.Google Scholar
- 41.J. Steiner and J. Singley, Methoxychlor removal from potable water. J. Am. Water Works Assoc. 17, 284–286 (1979).Google Scholar
- 42.Dobbs and Cohen, Carbon Adsorption for Toxic Organics, Report NO. EPA/ 600/8-80/023, US Environmental Protection Agency, Cincinnati, OH, 1980.Google Scholar
- 43.M. Kamrin, N. Hayden, B. Christian, D. Bennack, and F. D′Itri, Water Quality: Home Water Treatment Using Activated Carbon, WQ-13, Cooperative Extension Service, Purdue University, 1991.Google Scholar
- 44.EUROPA, Endocrine Disruptors Website, http://ec.europa.eu/environment/endocrine/index_en.htm July (2006).
- 45.Green Facts, Scientific Facts on Endocrine DisruptorsWebsite: http://www.greenfacts.org/endocrine-disruptors/links/index.htm (2006).
- 46.Gordon Research Conferences, Environmental endocrine disruptors, The Fifth Gordon Research Conference on Environmental endocrine disruptors Barga, Italy, tJune 4–9 (2006).Google Scholar